Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03979495 · ClinicalTrials.gov registry record · NA
mFOCUS (Multilevel FOllow-up of Cancer Screening)
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 11,980
- Enrollment target
NCT03979495: Completed NA study, sponsored by Massachusetts General Hospital.
NCT03979495 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 11,980 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03979495, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 11,980 participants
- Enrollment target
Study Summary
To evaluate the effectiveness of the system, team and individual components of mFOCUS vs. standard care by conducting a 4-arm cluster randomized controlled trial (RCT) of individuals who are due for follow-up of an abnormal cancer screening test.
Interventions
- OTHER mFOCUS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11,980 participants |
| Start Date | 2020-08-24 |
| Est. Completion | 2022-08-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03979495
The ClinicalTrials.gov registry entry for NCT03979495 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 11,980 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which mFOCUS is the first listed.
NCT03979495 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03979495 about?
NCT03979495 is a clinical study titled "mFOCUS (Multilevel FOllow-up of Cancer Screening)". To evaluate the effectiveness of the system, team and individual components of mFOCUS vs. standard care by conducting a 4-arm cluster randomized controlled trial (RCT) of individuals who are due for follow-up of an abnormal cancer screening test.
What is the current status of trial NCT03979495?
This trial is currently completed. It is a NA study. The enrollment target is 11,980 participants. The study started on 2020-08-24. Estimated completion is 2022-08-10.
What interventions are being tested in trial NCT03979495?
The interventions under investigation include: mFOCUS (OTHER).
Who is sponsoring clinical trial NCT03979495?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.